Neuroprotection in radiotherapy of brain metastases: A pattern-of-care analysis in Germany, Austria and Switzerland by the German Society for radiation Oncology - working group Neuro-Radio-Oncology (DEGRO AG-NRO).

In a comparison of facilities treating > 100 patients and facilities treating ≤ 50 patients per year, centers with many patients showed a trend for increased rates of using SRT for up to 10 BM (43 % vs. 19 %; p = 0.13), while HS-WBRT and memantine were equally frequently applied ( Fig. 4 b).

also in 53,322 other papers